Spotlight On... President Obama might transition into health tech venture capitalism; Medtronic and the World Stroke Organization are working to increase stroke awareness; Arkis BioSciences closes $3.4M Series A; and more...

President Barack Obama spoke with Bloomberg Businessweek about his interest in precision medicine and genetics, noting that becoming an investor in Silicon Valley would "pull together my interests in science and organization in a way I find really satisfying." Bloomberg interview

> Medtronic and the World Stroke Organization are collaborating on several initiatives to increase stroke awareness. Release

> Arkis BioSciences, which makes less invasive and more durable cerebrospinal fluid treatments, closed a $3.4 million Series A financing. Release

> Centric Medical's Subtalar Arthroereisis Implant System for the foot and ankle won FDA clearance. The one-piece titanium implant is for the correction of pathologic flatfoot deformities. Release

Suggested Articles

The two companies also plan to identify new potential targets and therapeutic candidates for inflammatory bowel disease, or IBD.

This would allow centralized, lab-based diagnostic hardware to process blood samples at scale, screening patients for previous infections.

GlaxoSmithKline and AstraZeneca are considering forming a joint lab to help the U.K. expand its supplies for COVID-19 testing, according to Bloomberg.